Geode Capital Management, LLC Virpax Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.76 - $1.1 $1,603 - $2,321	-2,110 Reduced 3.2%	63,928 $51,000
Q4 2022 Feb 13, 2023	SELL	$0.62 - $12.0 $114 - $2,220	-185 Reduced 0.28%	66,038 $41,000
Q2 2022 Aug 12, 2022	BUY	$1.22 - $2.25 $3,916 - $7,222	3,210 Added 5.09%	66,223 $111,000
Q1 2022 May 13, 2022	BUY	$1.86 - $3.61 $28,536 - $55,384	15,342 Added 32.18%	63,013 $139,000
Q4 2021 Feb 11, 2022	BUY	$3.19 - $4.89 $120,026 - $183,991	37,626 Added 374.57%	47,671 $163,000
Q3 2021 Nov 12, 2021	BUY	$4.14 - $22.9 $41,586 - $230,030	10,045 New	10,045 $48,000

Ticker VRPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,714,600
Market Cap $7.15M
Description
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.